
-
Rahm out to break 2025 win drought ahead of US PGA Championship
-
Japan tariff envoy departs for round two of US talks
-
Djurgarden eyeing Chelsea upset in historic Conference League semi-final
-
Haliburton leads comeback as Pacers advance, Pistons stay alive
-
Bunker-cafe on Korean border paints image of peace
-
Tunics & turbans: Afghan students don Taliban-imposed uniforms
-
Asian markets struggle as trade war hits China factory activity
-
Norwegian success story: Bodo/Glimt's historic run to a European semi-final
-
Spurs attempt to grasp Europa League lifeline to save dismal season
-
Thawing permafrost dots Siberia with rash of mounds
-
S. Korea prosecutors raid ex-president's house over shaman probe: Yonhap
-
Filipino cardinal, the 'Asian Francis', is papal contender
-
Samsung Electronics posts 22% jump in Q1 net profit
-
Pietro Parolin, career diplomat leading race to be pope
-
Nuclear submarine deal lurks below surface of Australian election
-
China's manufacturing shrinks in April as trade war bites
-
Financial markets may be the last guardrail on Trump
-
Swedish journalist's trial opens in Turkey
-
Kiss says 'honour of a lifetime' to coach Wallabies at home World Cup
-
US growth figure expected to make for tough reading for Trump
-
Opposition leader confirmed winner of Trinidad elections
-
Snedeker, Ogilvy to skipper Presidents Cup teams: PGA Tour
-
Win or bust in Europa League for Amorim's Man Utd
-
Trump celebrates 100 days in office with campaign-style rally
-
Top Cuban dissidents detained after court revokes parole
-
Arteta urges Arsenal to deliver 'special' fightback against PSG
-
Trump fires Kamala Harris's husband from Holocaust board
-
Pakistan says India planning strike as tensions soar over Kashmir attack
-
Weinstein sex attack accuser tells court he 'humiliated' her
-
France accuses Russian military intelligence over cyberattacks
-
Global stocks mostly rise as Trump grants auto tariff relief
-
Grand Vietnam parade 50 years after the fall of Saigon
-
Trump fires ex first gentleman Emhoff from Holocaust board
-
PSG 'not getting carried away' despite holding edge against Arsenal
-
Cuban dissidents detained after court revokes parole
-
Sweden stunned by new deadly gun attack
-
BRICS blast 'resurgence of protectionism' in Trump era
-
Trump tempers auto tariffs, winning cautious praise from industry
-
'Cruel measure': Dominican crackdown on Haitian hospitals
-
'It's only half-time': Defiant Raya says Arsenal can overturn PSG deficit
-
Dembele sinks Arsenal as PSG seize edge in Champions League semi-final
-
Les Kiss to take over Wallabies coach role from mid-2026
-
Real Madrid's Rudiger, Mendy and Alaba out injured until end of season
-
US threatens to quit Russia-Ukraine effort unless 'concrete proposals'
-
Meta releases standalone AI app, competing with ChatGPT
-
Zverev crashes as Swiatek scrapes into Madrid Open quarter-finals
-
BRICS members blast rise of 'trade protectionism'
-
Trump praises Bezos as Amazon denies plan to display tariff cost
-
France to tax small parcels from China amid tariff fallout fears
-
Hong Kong releases former opposition lawmakers jailed for subversion

US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
T.Suter--VB